Apriso and Micturition urgency - a phase IV clinical study of FDA data

Summary:

Micturition urgency is reported as a side effect among people who take Apriso (mesalamine), especially for people who are female, 60+ old, also take Xyrem, and have Narcolepsy.

The phase IV clinical study analyzes which people have Micturition urgency when taking Apriso. It is created by eHealthMe based on reports of 3,303 people who have side effects when taking Apriso from the FDA, and is updated regularly.

What is Apriso?

Apriso has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 3,439 Apriso users. Check the latest studies of Apriso.

What is Micturition urgency?

Micturition urgency (urgency to pass the urine) is found to be associated with 1,036 drugs and 874 conditions by eHealthMe. Check the latest studies of Micturition urgency.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

3,303 people reported to have side effects when taking Apriso.
Among them, 12 people (0.36%) have Micturition urgency.

Among these 12 people:

What is the gender of people who have Micturition urgency when taking Apriso? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Micturition urgency when taking Apriso? *

What are other drugs people take besides Apriso? *

What are other side effects people have besides Micturition urgency? *

Weight Decreased: 5 people, 41.67%
Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 5 people, 41.67%
Blood Pressure Fluctuation: 5 people, 41.67%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 5 people, 41.67%
Colon Cancer Stage Iii: 5 people, 41.67%
Lymphoma (cancer that begins in immune system cells): 5 people, 41.67%
Constipation: 3 people, 25.00%
Accident: 2 people, 16.67%
Diarrhea: 2 people, 16.67%
Headache (pain in head): 2 people, 16.67%

What are the existing conditions these people have? *

Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 41.67%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 41.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 25.00%
High Blood Cholesterol: 3 people, 25.00%
Muscle Aches (muscle pain): 3 people, 25.00%
Sleep Disorder: 2 people, 16.67%
Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 2 people, 16.67%
Calcium Deficiency (lack of calcium): 2 people, 16.67%
Diarrhea: 2 people, 16.67%
Energy Increased: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Apriso and have Micturition urgency?

- Check whether Micturition urgency is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Apriso:

Apriso (3,439 reports)

Browse all side effects of Apriso:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Micturition urgency:

Micturition urgency (1,036 drugs)

Browse all the conditions that are associated with Micturition urgency:

Micturition urgency (874 conditions)

Related publications that referenced our studies

Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on mesalamine (the active ingredients of Apriso) and Apriso (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.